Clinical Trial Update: Effect of Mesenchymal Stem Cells-derived Exosomes in Decompensated Liver Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating mesenchymal stem cell-derived exosomes for decompensated liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Liver Cirrhosis

Drugs mentioned

• Mesenchymal Stem Cell-Derived Exosomes

Snippet

Sponsor: Research Institute for Gastroenterology and Liver Diseases (RIGLD) | Conditions: Decompensated Liver Cirrhosis | Phase 2 | Status: UNKNOWN